Definition of a p53 transactivation function-deficient mutant and characterization of two independent p53 transactivation subdomains

被引:63
作者
Venot, C [1 ]
Maratrat, M [1 ]
Sierra, V [1 ]
Conseiller, E [1 ]
Debussche, L [1 ]
机构
[1] Rhone Poulenc Rorer, Ctr Rech Vitry Alfortville, F-94403 Vitry Sur Seine, France
关键词
p53; apoptosis; transactivation; repression; PIG3;
D O I
10.1038/sj.onc.1202539
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The wild-type protein product of the p53 tumor suppressor gene can activate transcription of genes which are involved in mediating either growth arrest, e.g. WAF1 or apoptotis, e.g. BAX and PIG3. Additionally, p53 can repress a variety of promoters, which, in turn, may be responsible for the functional activities exhibited by p53. This study shows that the Q22, S23 double mutation, which is known to inactivate a p53 transactivation subdomain located within the initial 40 residues of the protein, while abrogating transactivation from the WAF1 promoter, only attenuates apoptosis triggering, transactivation from other p53-responsive promoters and repression of promoters by p53. The Q53, S54 double mutation, which inactivates another p53 transactivation subdomain situated between amino acids 43 and 73 results in attenuation of all of the aforementioned p53 activities. In contrast to the Q22, S23 double mutation, this latter mutation set does not alter mdm-2-mediated inhibition and degradation of p53. Finally, mutation of all four residues results in complete abrogation of every p53 activity mentioned above.
引用
收藏
页码:2405 / 2410
页数:6
相关论文
共 47 条
[1]   A PROTEOLYTIC FRAGMENT FROM THE CENTRAL REGION OF P53 HAS MARKED SEQUENCE-SPECIFIC DNA-BINDING ACTIVITY WHEN GENERATED FROM WILD-TYPE BUT NOT FROM ONCOGENIC MUTANT P53-PROTEIN [J].
BARGONETTI, J ;
MANFREDI, JJ ;
CHEN, XB ;
MARSHAK, DR ;
PRIVES, C .
GENES & DEVELOPMENT, 1993, 7 (12B) :2565-2574
[2]   p53 in signaling checkpoint arrest or apoptosis [J].
Bates, S ;
Vousden, KH .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 1996, 6 (01) :12-18
[3]   INDUCTION OF THE GROWTH INHIBITOR IGF-BINDING PROTEIN-3 BY P53 [J].
BUCKBINDER, L ;
TALBOTT, R ;
VELASCOMIGUEL, S ;
TAKENAKA, I ;
FAHA, B ;
SEIZINGER, BR ;
KLEY, N .
NATURE, 1995, 377 (6550) :646-649
[4]   P53-DEPENDENT APOPTOSIS IN THE ABSENCE OF TRANSCRIPTIONAL ACTIVATION OF P53-TARGET GENES [J].
CAELLES, C ;
HELMBERG, A ;
KARIN, M .
NATURE, 1994, 370 (6486) :220-223
[5]   Two tandem and independent sub-activation domains in the amino terminus of p53 require the adaptor complex for activity [J].
Candau, R ;
Scolnick, DM ;
Darpino, P ;
Ying, CY ;
Halazonetis, TD ;
Berger, SL .
ONCOGENE, 1997, 15 (07) :807-816
[6]   TRANSACTIVATION ABILITY OF P53 TRANSCRIPTIONAL ACTIVATION DOMAIN IS DIRECTLY RELATED TO THE BINDING-AFFINITY TO TATA-BINDING PROTEIN [J].
CHANG, J ;
KIM, DH ;
LEE, SW ;
CHOI, KY ;
SUNG, YC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (42) :25014-25019
[7]   p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells [J].
Chen, XB ;
Ko, LJ ;
Jayaraman, L ;
Prives, C .
GENES & DEVELOPMENT, 1996, 10 (19) :2438-2451
[8]   CRYSTAL-STRUCTURE OF A P53 TUMOR-SUPPRESSOR DNA COMPLEX - UNDERSTANDING TUMORIGENIC MUTATIONS [J].
CHO, YJ ;
GORINA, S ;
JEFFREY, PD ;
PAVLETICH, NP .
SCIENCE, 1994, 265 (5170) :346-355
[9]   HIGH-RESOLUTION STRUCTURE OF THE OLIGOMERIZATION DOMAIN OF P53 BY MULTIDIMENSIONAL NMR [J].
CLORE, GM ;
OMICHINSKI, JG ;
SAKAGUCHI, K ;
ZAMBRANO, N ;
SAKAMOTO, H ;
APPELLA, E ;
GRONENBORN, AM .
SCIENCE, 1994, 265 (5170) :386-391
[10]   CTS1: A p53-derived chimeric tumor suppressor gene with enhanced in vitro apoptotic properties [J].
Conseiller, E ;
Debussche, L ;
Landais, D ;
Venot, C ;
Maratrat, M ;
Sierra, V ;
Tocque, B ;
Bracco, L .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (01) :120-127